Records containing: Neutropenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-06-04Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia Due to Enterobacteriaceae and Pseudomonas Aeruginosa in Hemato-oncological Patients With Severe Neutropenia and Fever: Non-inferiority Study
-
CLINICAL_TRIALS study record update · 2024-05-21A Comparator Study of a Tasso Device to Traditional Venous Blood Sampling Methods for Complete Blood Count (CBC) With 5-part Differential in Patients With Leukemia, Lymphoma, and/or Other Blood Cell Disorders
-
CLINICAL_TRIALS study record update · 2024-03-22Natural History and Molecular Characterization of Benign Ethnic Neutropenia in Individuals of African Descent
-
CLINICAL_TRIALS study record update · 2024-03-19A Randomized Controlled Study Comparing Different Doses of Pegfilgrastim as Support for Adjuvant Chemotherapy for Breast Cancer
-
CLINICAL_TRIALS study record update · 2024-03-04Phase I Study of BMS-247550 in Patients With Refractory Neoplasms
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-02-23A Single-Center, Open-Label, Dose-Escalation Phase I Clinical Trial of Recombinant Human Granulocyte Colony Stimulating Factor-Fc Fusion Protein for Injection as an Adjuvant to Chemotherapy in Subjects With Breast Cancer
-
CLINICAL_TRIALS study record update · 2023-12-27A Randomized, Multicenter, Open-Label Study of Single Dose Filgrastim-SD/01 Versus Daily Filgrastim Following ESHAP Chemotherapy for Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2023-10-30Retrospective Study on the Hematological Effects of Atypical Antipsychotics (AAPs) in a Geriatric Population: What is the Role of 5-HT2 Receptors
-
CLINICAL_TRIALS study record update · 2023-09-06Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
-
CLINICAL_TRIALS study record update · 2023-07-13Neutrocheck Summative Usability Study
-
CLINICAL_TRIALS study record update · 2023-04-07A Phase III Double-Blind Randomized Crossover Study of Plerixafor Versus G-CSF in the Treatment of Patients With WHIM Syndrome.
-
CLINICAL_TRIALS study record update · 2023-03-31Efficacy of an Antimicrobial Stewardship Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients
-
CLINICAL_TRIALS study record update · 2023-02-10Using Next Gen Sequencing to Identify Pediatric Patients With Febrile Neutropenia at Low Risk for Complications: A Pilot Study
-
CLINICAL_TRIALS study record update · 2023-02-02Treatment of Poor Prognosis Acute Myeloid Leukemia and Blastic Crisis Chronic Myelogenous Leukemia With Mylotarg, High-Dose Cytarabine, Mitozantrone and Ethyol AML/CML 2000-06.
-
CLINICAL_TRIALS study record update · 2023-01-05A Multicenter, Phase Ib/II Trial of the Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cells in Treatment-induced Myelosuppression in Patients With Hematologic Malignancies (USMYE Trial)
-
CLINICAL_TRIALS study record update · 2022-10-21Evaluation of Lithium Efficacy Against Chemotherapy Induced Neutropenia in Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2022-10-20Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study
-
CLINICAL_TRIALS study record update · 2022-08-18Late Neutropenia in VLBW Preterm Babies - Characterization and Post Natal Menagement
-
CLINICAL_TRIALS study record update · 2022-04-15Phase 2, Open-Label, Dose-Ranging Study of SPI-2012 (HM10460A) or Pegfilgrastim Use for the Management of Neutropenia in Patients With Breast Cancer Who Are Candidates for Adjuvant and Neoadjuvant Chemotherapy With the Docetaxel + Cyclophosphamide (TC) Regimen
-
CLINICAL_TRIALS study record update · 2022-04-06Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies (SCENE)
-
CLINICAL_TRIALS study record update · 2022-03-02RAnDomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast CANCEr Patients Receiving Docetaxel and Cyclophosphamide (TC) (ADVANCE)
-
CLINICAL_TRIALS study record update · 2022-03-02Randomized, OpEn-Label, Active-ContrOl Trial of SPI-2012 (Eflapegrastim) Versus Pegfilgrastim in the Management of Chemotherapy-Induced Neutropenia in Early-Stage BReast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) (RECOVER)
-
CLINICAL_TRIALS study record update · 2021-09-24A Phase II Study of Isavuconazole Prophylaxis in Adult Patients With AML/MDS and Neutropenia
-
CLINICAL_TRIALS study record update · 2021-05-07A Phase III, Randomized, Multi-Centre, Open-Label, Fixed Dose, Neulasta® Active-Controlled Clinical Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
-
CLINICAL_TRIALS study record update · 2021-04-27Fever and Neutropenia in Pediatric Oncology Patients: A Randomized, Controlled, Multi-Center Study of Outpatient Therapy Evaluation of Genomic and Proteomic Correlates